K41-A enhances the antiproliferative efficacy of cisplatin in neuroblastoma by modulating apoptosis and autophagy
Journal of Pharmacy and Pharmacology · 2026
DOI: 10.1093/jpp/rgaf131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Gamze Sanlav und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Oncology, Dokuz Eylul University, Izmir 35330, Turkey. Hauptthemen laut MEDLINE: Cisplatin, Neuroblastoma, Apoptosis, Autophagy. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Institutes of Turkey, Dokuz Eylul University Department of Scientific Research Projects.
Abstract (Originalsprache)
Objectives
Neuroblastoma (NB), the most common extracranial tumor in childhood, has a poor prognosis, especially in cases with MYC gene amplification. Cisplatin (CDDP) is widely used in treatment, but its effectiveness is limited due to chemotherapy resistance. Autophagy plays a dual role in cancer progression, either promoting survival or contributing to cell death.
Methods
This study explores the anticancer effects of K41-A, a polycyclic polyether molecule, alone and in combination with CDDP in SH-SY5Y and KELLY NB cell lines, the HE-IOC1 noncancerous cochlear cell line, and the NB xenograft model. Key findings For the first time, we demonstrate that K41-A, either alone or combined with CDDP, significantly inhibits cell proliferation selectively in NB cells, sparing noncancerous cells. This study confirmed that K41-A alone and in combination with CDDP induced changes in both apoptotic and autophagic cell death components in NB, resulting in antiproliferative activity in vitro and in vivo. In addition, the combination with CDDP enhanced the therapeutic efficacy of K41-A.
Conclusions
These results highlight the potential of K41-A as a candidate drug for the treatment of NB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Oncology, Dokuz Eylul University, Izmir 35330, Turkey.
- Department of Bioenginering, Izmir Institute of Technology, Izmir 35430, Turkey.
- Department of Pediatric Oncology, Dokuz Eylul University, Izmir 35330, Turkey.
ORCID-Profile: Zekiye Altun
Förderung
- Health Institutes of Turkey
- Dokuz Eylul University Department of Scientific Research Projects
Zitieren
APA
Sanlav, G., Kum Ozsengezer, S., Altun, Z., Bedir, E., Aktas, S., & Olgun, N. (2026). K41-A enhances the antiproliferative efficacy of cisplatin in neuroblastoma by modulating apoptosis and autophagy. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf131
Vancouver
Sanlav G, Kum Ozsengezer S, Altun Z, Bedir E, Aktas S, Olgun N. K41-A enhances the antiproliferative efficacy of cisplatin in neuroblastoma by modulating apoptosis and autophagy. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgaf131
BibTeX
@article{Sanlav2026,
author = {Sanlav, Gamze and Kum Ozsengezer, Selen and Altun, Zekiye and Bedir, Erdal and Aktas, Safiye and Olgun, Nur},
title = {K41-A enhances the antiproliferative efficacy of cisplatin in neuroblastoma by modulating apoptosis and autophagy},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
doi = {10.1093/jpp/rgaf131}
}
EUVIMED